ʻO Sacubitril Hemicalcium

Hōʻike Pōkole:

Ka inoa o API Hōʻike Hoakaka US DMF  EU DMF  CEP
ʻO Sacubitril Hemicalcium   Ma-Hale      

ʻIke kikoʻī

Nā huahana huahana

ʻIkepili Huahana

    库 比 曲 半 钙盐 ʻO Sacubitril Hemicalcium 1369773-39-6 Ma-Hale
    库 比 曲 钠盐 149690-05-1 Ma-Hale
    LCZ-4 1426129-50-1 Ma-Hale
    LCZ-7 1012341-48-8 Ma-Hale
    LCZ-8 1012341-50-2 Ma-Hale
    LCZ-9 149690-12-0 Ma-Hale

 

Papa kāʻei kua

ʻO ka AHU-377 hemicalcium paʻakai kahi paʻakai hemicalcium o AHU-377. He mea kāohi ia o neprilysin me ka waiwai IC50 o 5 nM [1].

ʻO AHU-377 a me ka angiotensin II AT1 receptor antagonist valsartan e haku LCZ696 i ka lakio molar 1: 1. ʻO LCZ696 kahi mea loaʻa i ka mea ʻenemi angiotensin neprilysin. Hiki iā ia ke hoʻemi i ke kahe o ke koko a lilo paha i lāʻau lapaʻau no ka mālama ʻana i ka maikaʻi ʻole o ka naʻau. ʻO ka AHU-377 kahi lāʻau lapaʻau pro-pro, hiki ke hoʻololi ʻia e ka cleavage enzymatic o ka etyl ester i loko o ka palapala hana LBQ657. Ua hōʻike ʻia ʻo AHU-377 (30 a me 100 mg / kg, PO) hiki ke hana i ka hopena antihypertensive i kahi ʻano hilinaʻi ma ka lāʻau ma nā ʻiole DAHI-SS. Akā i nāʻiole hypertensive DOCA-paʻakai, hōʻike ia i kahi hōʻemi nāwaliwali [2, 3].

Nā kūmole:
[1] Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. Dicarboxylic acid dipeptide kūpale endopeptidase nā mea kūpale. ʻO J Med Chem. 1995 Mei 12; 38 (10): 1689-700.
[2] Voors AA, Dorhout B, van der Meer P. Ke kuleana kūpono o valsartan + AHU377 (LCZ696) i ka mālama ʻana i ka naʻau ʻole. ʻO nā lāʻau lapaʻau Opin Investig Expert. 2013 ʻAuk; 22 (8): 1041-7.
[3] Laxminarayan G Hegde, Cecile Yu, Cheruvu Madhavi et al. ʻO ka pono hoʻohālikelike o AHU-377, kahi mea hoʻokiwaliwali neprilysin ikaika, i loko o nā ʻano ʻiole ʻelua o ke kiʻekiʻe kiʻekiʻe hilinaʻi nui. BMC Pharmacology 2011, 11 (Hōʻawi 1): P33.

ʻAno kemika

Sacubitril Hemicalcium

CERTIFICATE

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

KA MANAWAI ANA

Quality management1

Palapala Noi 18 Nā papahana loiloi e like me ka Consistency i ʻae ʻia 4, a 6 ke ʻae ʻia nei nā papahana.

Quality management2

Ua hoʻokumu ʻia ka ʻōnaehana hoʻokele kūlana kiʻekiʻe kiʻekiʻe loa no ke kūʻai aku.

Quality management3

Holo ka nānā ʻana i ka maikaʻi ma waena o ke ola holoʻokoʻa o ka huahana e hōʻoia i ka maikaʻi a me ka hopena therapeutic. 

Quality management4

Kākoʻo ka ʻoihana Hoʻokele ʻoihana ʻoihana i nā koi maikaʻi i ka wā o ka noi a me ke kau inoa.

MANAGEMENT HUA

cpf5
cpf6

Kōleka Packaging ʻōmole Korea

cpf7
cpf8

ʻO ka laina Packaging ʻōmole ʻo Taiwan CVC

cpf9
cpf10

ʻO ka laina Packaging Papa CAM Italia

cpf11

Mīkini Pīkī Fette Kelemania

cpf12

ʻO Iapana Viswill Tablet Detector

cpf14-1

Rumi Nahenahe DCS

HOA HOA

ʻO ke alu like ʻana me ka honua
International cooperation
Hana kūloko
Domestic cooperation

  • Kekahi:
  • Aʻe:

  • Kākau i kāu leka ma aneʻi a hoʻouna iā mākou